Akèy › Twoub Defisi Atansyon ak Ipèaktivite › Alabama
Etid klinik pou Twoub Defisi Atansyon ak Ipèaktivite nan Alabama
4 etid pou Twoub Defisi Atansyon ak Ipèaktivite ap chèche patisipan nan sit nan Alabama.
Tèks ofisyèl etid la (Anglè)
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- The Center for Clinical Trials, Inc., Saraland
Ap rekriteFaz 4
48 Months – 69 Months · Tout sèks · Mizajou Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Dothan
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Dothan
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717892Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Aug 19, 2026 · NCT05776056Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.